STOCK TITAN

[8-K] LADDER CAPITAL CORP Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

UnitedHealth Group (UNH) filed an 8-K disclosing that the U.S. Department of Justice has opened formal criminal and civil inquiries into certain aspects of the company’s Medicare and Medicare Advantage activities. UNH says it proactively contacted the DOJ after media reports surfaced and is now supplying requested information.

The company emphasizes:

  • Independent CMS audits have found its risk-adjustment coding practices "among the most accurate in the industry."
  • A decade-long civil case on Medicare Advantage practices ended with a court-appointed Special Master finding no evidence of wrongdoing.
  • UNH has launched third-party reviews of risk-assessment coding, managed-care practices and pharmacy services to enhance transparency.

Management states full confidence in existing compliance controls but cautions that investigation outcomes are unpredictable and could materially differ from current expectations, as noted in the forward-looking-statement disclaimer.

UnitedHealth Group (UNH) ha presentato un modulo 8-K comunicando che il Dipartimento di Giustizia degli Stati Uniti ha avviato indagini penali e civili formali su alcuni aspetti delle attività Medicare e Medicare Advantage della società. UNH dichiara di aver proattivamente contattato il DOJ dopo la diffusione di alcune notizie mediatiche e sta ora fornendo le informazioni richieste.

L'azienda sottolinea:

  • Audit indipendenti del CMS hanno rilevato che le sue pratiche di codifica per l'aggiustamento del rischio sono "tra le più accurate del settore."
  • Una causa civile durata un decennio sulle pratiche Medicare Advantage si è conclusa con un Master Speciale nominato dal tribunale che non ha trovato prove di illeciti.
  • UNH ha avviato revisioni da parte di terzi sulla codifica della valutazione del rischio, sulle pratiche di assistenza gestita e sui servizi farmaceutici per aumentare la trasparenza.

La direzione esprime piena fiducia nei controlli di conformità esistenti, ma avverte che i risultati dell'indagine sono imprevedibili e potrebbero differire sostanzialmente dalle aspettative attuali, come indicato nella clausola di esonero sulle dichiarazioni previsionali.

UnitedHealth Group (UNH) presentó un formulario 8-K informando que el Departamento de Justicia de EE.UU. ha iniciado investigaciones penales y civiles formales sobre ciertos aspectos de las actividades de Medicare y Medicare Advantage de la compañía. UNH afirma que proactivamente contactó al DOJ tras la aparición de reportes mediáticos y ahora está proporcionando la información solicitada.

La empresa enfatiza:

  • Auditorías independientes del CMS han encontrado que sus prácticas de codificación para el ajuste de riesgo están "entre las más precisas de la industria."
  • Un caso civil de una década sobre prácticas de Medicare Advantage terminó con un Maestro Especial designado por la corte que no encontró evidencia de conducta indebida.
  • UNH ha iniciado revisiones de terceros sobre la codificación de evaluación de riesgos, prácticas de atención administrada y servicios farmacéuticos para mejorar la transparencia.

La gerencia expresa plena confianza en los controles de cumplimiento existentes, pero advierte que los resultados de la investigación son impredecibles y podrían diferir materialmente de las expectativas actuales, como se señala en la cláusula de exención de declaraciones prospectivas.

UnitedHealth Group(UNH)는 미국 법무부가 회사의 메디케어 및 메디케어 어드밴티지 활동과 관련된 특정 사안에 대해 형사 및 민사 조사를 공식적으로 개시했다고 8-K 보고서를 통해 공개했습니다. UNH는 언론 보도가 나온 후 선제적으로 법무부에 연락했으며 현재 요청받은 정보를 제공하고 있다고 밝혔습니다.

회사는 다음과 같이 강조합니다:

  • 독립적인 CMS 감사에서 위험 조정 코딩 관행이 "업계에서 가장 정확한 편에 속한다"고 평가받았습니다.
  • 메디케어 어드밴티지 관행에 관한 10년간의 민사 소송은 법원이 지정한 특별 관리인이 위법 행위 증거가 없다고 결론지었습니다.
  • UNH는 투명성을 높이기 위해 위험 평가 코딩, 관리 의료 관행 및 약국 서비스에 대해 제3자 검토를 시작했습니다.

경영진은 기존 준수 통제에 대해 전적인 신뢰를 표명하지만, 조사 결과는 예측 불가능하며 현재 기대와 크게 다를 수 있다고 전망 진술 면책 조항에서 언급했습니다.

UnitedHealth Group (UNH) a déposé un formulaire 8-K révélant que le ministère de la Justice des États-Unis a ouvert des enquêtes pénales et civiles formelles sur certains aspects des activités Medicare et Medicare Advantage de la société. UNH indique avoir proactivement contacté le DOJ après la diffusion de rapports médiatiques et fournit désormais les informations demandées.

L'entreprise souligne :

  • Des audits indépendants du CMS ont conclu que ses pratiques de codage pour l'ajustement des risques figurent « parmi les plus précises de l'industrie ».
  • Une affaire civile de dix ans concernant les pratiques Medicare Advantage s'est terminée avec un maître spécial nommé par le tribunal qui n'a trouvé aucune preuve de faute.
  • UNH a lancé des revues tierces des codages d'évaluation des risques, des pratiques de soins gérés et des services pharmaceutiques pour renforcer la transparence.

La direction exprime une confiance totale dans les contrôles de conformité existants, mais avertit que les résultats de l'enquête sont imprévisibles et pourraient différer sensiblement des attentes actuelles, comme indiqué dans la clause de non-responsabilité relative aux déclarations prospectives.

UnitedHealth Group (UNH) hat in einem 8-K-Bericht offengelegt, dass das US-Justizministerium formelle straf- und zivilrechtliche Untersuchungen zu bestimmten Aspekten der Medicare- und Medicare Advantage-Aktivitäten des Unternehmens eingeleitet hat. UNH gibt an, dass es proaktiv das DOJ kontaktiert hat, nachdem Medienberichte aufgetaucht waren, und nun die angeforderten Informationen bereitstellt.

Das Unternehmen betont:

  • Unabhängige CMS-Prüfungen haben festgestellt, dass seine Risikoanpassungs-Codierungspraktiken „zu den genauesten der Branche gehören“.
  • Ein zehnjähriger Zivilprozess zu Medicare Advantage-Praktiken endete mit einem gerichtlich bestellten Sonderbeauftragten, der keine Beweise für Fehlverhalten fand.
  • UNH hat Drittprüfungen der Risikobewertungscodierung, der Managed-Care-Praktiken und der Apothekendienstleistungen eingeleitet, um die Transparenz zu erhöhen.

Das Management äußert volles Vertrauen in die bestehenden Compliance-Kontrollen, warnt jedoch, dass die Ergebnisse der Untersuchung unvorhersehbar sind und wesentlich von den aktuellen Erwartungen abweichen können, wie im Haftungsausschluss für zukunftsgerichtete Aussagen angegeben.

Positive
  • Proactive cooperation with DOJ may reduce potential penalties.
  • Independent CMS audits previously validated coding accuracy, supporting defense narrative.
  • Company has initiated third-party reviews to enhance transparency and compliance oversight.
Negative
  • Formal DOJ criminal and civil investigations create material legal and reputational risk.
  • Potential for higher legal costs, fines or program limitations remains uncertain.
  • Regulatory overhang could pressure valuation and investor sentiment until resolved.

Insights

TL;DR: DOJ probes add headline risk; no immediate financial hit yet disclosed.

The initiation of formal criminal and civil inquiries into UNH’s Medicare practices introduces regulatory overhang that could weigh on valuation multiples until resolved. While management cites favorable CMS audit history and a prior civil win, the scope and duration of new investigations are unknown. Legal expenses may rise and, in a worst-case scenario, could lead to restitution, fines or program-participation limits. Proactive third-party reviews may shorten resolution time and signal governance strength, but investors should expect near-term sentiment pressure.

TL;DR: Compliance posture strong, yet criminal inquiry elevates downside tail risk.

UNH’s self-reporting and cooperation align with DOJ best-practice guidelines, potentially mitigating penalties. Historic CMS audit accuracy and prior legal vindication are supportive defenses. Nevertheless, criminal investigations into Medicare Advantage coding can trigger multi-year scrutiny across business lines, elevate False Claims Act exposure and invite parallel state actions. Third-party audits are a positive remedial measure, but investors should model higher legal contingencies until greater clarity emerges.

UnitedHealth Group (UNH) ha presentato un modulo 8-K comunicando che il Dipartimento di Giustizia degli Stati Uniti ha avviato indagini penali e civili formali su alcuni aspetti delle attività Medicare e Medicare Advantage della società. UNH dichiara di aver proattivamente contattato il DOJ dopo la diffusione di alcune notizie mediatiche e sta ora fornendo le informazioni richieste.

L'azienda sottolinea:

  • Audit indipendenti del CMS hanno rilevato che le sue pratiche di codifica per l'aggiustamento del rischio sono "tra le più accurate del settore."
  • Una causa civile durata un decennio sulle pratiche Medicare Advantage si è conclusa con un Master Speciale nominato dal tribunale che non ha trovato prove di illeciti.
  • UNH ha avviato revisioni da parte di terzi sulla codifica della valutazione del rischio, sulle pratiche di assistenza gestita e sui servizi farmaceutici per aumentare la trasparenza.

La direzione esprime piena fiducia nei controlli di conformità esistenti, ma avverte che i risultati dell'indagine sono imprevedibili e potrebbero differire sostanzialmente dalle aspettative attuali, come indicato nella clausola di esonero sulle dichiarazioni previsionali.

UnitedHealth Group (UNH) presentó un formulario 8-K informando que el Departamento de Justicia de EE.UU. ha iniciado investigaciones penales y civiles formales sobre ciertos aspectos de las actividades de Medicare y Medicare Advantage de la compañía. UNH afirma que proactivamente contactó al DOJ tras la aparición de reportes mediáticos y ahora está proporcionando la información solicitada.

La empresa enfatiza:

  • Auditorías independientes del CMS han encontrado que sus prácticas de codificación para el ajuste de riesgo están "entre las más precisas de la industria."
  • Un caso civil de una década sobre prácticas de Medicare Advantage terminó con un Maestro Especial designado por la corte que no encontró evidencia de conducta indebida.
  • UNH ha iniciado revisiones de terceros sobre la codificación de evaluación de riesgos, prácticas de atención administrada y servicios farmacéuticos para mejorar la transparencia.

La gerencia expresa plena confianza en los controles de cumplimiento existentes, pero advierte que los resultados de la investigación son impredecibles y podrían diferir materialmente de las expectativas actuales, como se señala en la cláusula de exención de declaraciones prospectivas.

UnitedHealth Group(UNH)는 미국 법무부가 회사의 메디케어 및 메디케어 어드밴티지 활동과 관련된 특정 사안에 대해 형사 및 민사 조사를 공식적으로 개시했다고 8-K 보고서를 통해 공개했습니다. UNH는 언론 보도가 나온 후 선제적으로 법무부에 연락했으며 현재 요청받은 정보를 제공하고 있다고 밝혔습니다.

회사는 다음과 같이 강조합니다:

  • 독립적인 CMS 감사에서 위험 조정 코딩 관행이 "업계에서 가장 정확한 편에 속한다"고 평가받았습니다.
  • 메디케어 어드밴티지 관행에 관한 10년간의 민사 소송은 법원이 지정한 특별 관리인이 위법 행위 증거가 없다고 결론지었습니다.
  • UNH는 투명성을 높이기 위해 위험 평가 코딩, 관리 의료 관행 및 약국 서비스에 대해 제3자 검토를 시작했습니다.

경영진은 기존 준수 통제에 대해 전적인 신뢰를 표명하지만, 조사 결과는 예측 불가능하며 현재 기대와 크게 다를 수 있다고 전망 진술 면책 조항에서 언급했습니다.

UnitedHealth Group (UNH) a déposé un formulaire 8-K révélant que le ministère de la Justice des États-Unis a ouvert des enquêtes pénales et civiles formelles sur certains aspects des activités Medicare et Medicare Advantage de la société. UNH indique avoir proactivement contacté le DOJ après la diffusion de rapports médiatiques et fournit désormais les informations demandées.

L'entreprise souligne :

  • Des audits indépendants du CMS ont conclu que ses pratiques de codage pour l'ajustement des risques figurent « parmi les plus précises de l'industrie ».
  • Une affaire civile de dix ans concernant les pratiques Medicare Advantage s'est terminée avec un maître spécial nommé par le tribunal qui n'a trouvé aucune preuve de faute.
  • UNH a lancé des revues tierces des codages d'évaluation des risques, des pratiques de soins gérés et des services pharmaceutiques pour renforcer la transparence.

La direction exprime une confiance totale dans les contrôles de conformité existants, mais avertit que les résultats de l'enquête sont imprévisibles et pourraient différer sensiblement des attentes actuelles, comme indiqué dans la clause de non-responsabilité relative aux déclarations prospectives.

UnitedHealth Group (UNH) hat in einem 8-K-Bericht offengelegt, dass das US-Justizministerium formelle straf- und zivilrechtliche Untersuchungen zu bestimmten Aspekten der Medicare- und Medicare Advantage-Aktivitäten des Unternehmens eingeleitet hat. UNH gibt an, dass es proaktiv das DOJ kontaktiert hat, nachdem Medienberichte aufgetaucht waren, und nun die angeforderten Informationen bereitstellt.

Das Unternehmen betont:

  • Unabhängige CMS-Prüfungen haben festgestellt, dass seine Risikoanpassungs-Codierungspraktiken „zu den genauesten der Branche gehören“.
  • Ein zehnjähriger Zivilprozess zu Medicare Advantage-Praktiken endete mit einem gerichtlich bestellten Sonderbeauftragten, der keine Beweise für Fehlverhalten fand.
  • UNH hat Drittprüfungen der Risikobewertungscodierung, der Managed-Care-Praktiken und der Apothekendienstleistungen eingeleitet, um die Transparenz zu erhöhen.

Das Management äußert volles Vertrauen in die bestehenden Compliance-Kontrollen, warnt jedoch, dass die Ergebnisse der Untersuchung unvorhersehbar sind und wesentlich von den aktuellen Erwartungen abweichen können, wie im Haftungsausschluss für zukunftsgerichtete Aussagen angegeben.

0001577670FALSE00015776702025-07-242025-07-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 24, 2025

Ladder Capital Corp
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction
of incorporation)
001-36299
(Commission
File Number)
80-0925494
(I.R.S. Employer
Identification No.)
320 Park Avenue, 15th Floor
New York, New York
(Address of principal executive offices)
10022
(Zip Code)

Registrant’s telephone number, including area code: 212-715-3170
Not Applicable
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Class A common stock, $0.001 par valueLADRNew York Stock Exchange

1


Item 2.02.  Results of Operations and Financial Condition.
On July 24, 2025, Ladder Capital Corp (“Ladder”) issued a press release disclosing financial results for the quarter ended June 30, 2025. The information in Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.  Financial Statements and Exhibits.
    (d)    Exhibits
    
    99.1    Press release of Ladder Capital Corp dated July 24, 2025.

    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)



2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 24, 2025                    LADDER CAPITAL CORP
                            By: /s/ Paul J. Miceli
                             Paul J. Miceli
                             Chief Financial Officer

3

FAQ

Why did UnitedHealth Group (UNH) file this Form 8-K?

The filing notifies investors that UNH is now subject to formal DOJ criminal and civil investigations into aspects of its Medicare business.

Has UNH admitted any wrongdoing in its Medicare practices?

No. UNH states it has full confidence in its practices and cites prior audits and legal findings that showed no wrongdoing.

What steps is UNH taking to address the DOJ inquiries?

The company proactively contacted the DOJ, is complying with information requests, and has launched third-party reviews of risk-coding and managed-care processes.

Could the investigations affect UNH’s financial results?

While no financial impact was disclosed, criminal and civil probes can lead to fines, restitution or increased legal costs, posing downside risk.

How long might the DOJ investigations into UNH last?

The duration is uncertain; similar healthcare investigations often span multiple years. UNH cautioned that outcomes are unpredictable.
Ladder Cap Corp

NYSE:LADR

LADR Rankings

LADR Latest News

LADR Latest SEC Filings

LADR Stock Data

1.41B
112.19M
12.14%
64.32%
0.68%
REIT - Mortgage
Real Estate Investment Trusts
Link
United States
NEW YORK